Previously, Eliquis was only approved to reduce the risk of stroke and blood clots for patients with atrial fibrilliation not caused by a heart valve problem.
More Articles on FDA Approvals:
FDA Approves Migraine ‘Headband’ for Marketing
FDA Approves Myalept to Treat Lipodystrophy Complications
Medtronic Receives FDA 510(k) Clearance for Reveal LINQ Insertable Cardiac Monitor
